Latest news with #EmiratiGenomeProgram
Economic Times
24-06-2025
- Health
- Economic Times
Rewriting the health playbook: How Abu Dhabi is scaling AI and digital care
In April 2025, global health leaders, policymakers, innovators, and researchers convened for Abu Dhabi Global Health Week (ADGHW)—a flagship initiative of the Department of Health – Abu Dhabi (DoH). Held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, the year-round global platform advances transformative solutions across health and life sciences. Health doesn't operate in a silo; it calls for critical thinking and collaboration among practitioners, policymakers, pharmaceutical leaders, researchers, and frontline healthcare workers accelerating shared health ambitions worldwide. ADVERTISEMENT The 2025 theme, 'Towards Longevity: Redefining Health and Well-being,' mirrors ADGHW's ambition: shifting from episodic treatment to continuous, preventive, and personalised care. The promise of digital health and AI One pressing theme that has dominated the public health discourse in the past few years is digital health and artificial intelligence (AI). Advanced technologies are unlocking new frontiers by improving access, enhancing clinical outcomes, and supporting more resilient health systems. From remote monitoring, AI-diagnostics, to telemedicine and predictive analysis, Abu Dhabi is reimagining care pathways to deliver personalised treatment while empowering providers with real-time, data-driven insights. H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi According to H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, 'Digital health allows us to tailor care to the needs of each individual while improving access across diverse communities. Whether through telemedicine platforms or data-enabled prevention strategies, our focus is on strengthening system resilience and enhancing patient outcomes.' Abu Dhabi's growing trust-based health data and technical infrastructure presents a fertile ground for innovation. Initiatives such as Malaffi, the region's first Health Information Exchange, and the Emirati Genome Program are central to this vision. While the former facilitates real-time data sharing among care providers, the latter creates a unique dataset to analyse genetic predispositions to build better individual and population-level responses in health management. India's interest in scaling population health genomics (through initiatives such as the Genome India project, which aims to map the genetic diversity of the Indian population) aligns with such frameworks in Abu Dhabi. Data governance, ethical AI usage, and consent frameworks are some of the fronts where cross-border collaboration could be envisioned. ADVERTISEMENT Innovation Through Strategic InitiativesInitiatives announced at ADGHW 2025 reflect Abu Dhabi's role as a global health innovation leader, unveiling a suite of bold new initiatives that move digital health from concept to execution. ADVERTISEMENT Notably, the launch of the Health, Endurance, Longevity, and Medicine (HELM) Cluster—a partnership between the Abu Dhabi Investment Office, Mohamed bin Zayed University of Artificial Intelligence, and Hub71—signals a bold step toward advancing health life sciences, R&D, and building a robust ecosystem for medical innovation, pharmaceutical manufacturing, and biotechnology. The Startup Zone and Smart Health Hackathon spotlighted emerging innovators tackling real-world health challenges through AI-powered and digital-first approaches. The inaugural ADGHW Innovation Awards were also introduced, recognising breakthroughs that are driving meaningful improvements in patient outcomes, healthcare accessibility, and system efficiency. ADVERTISEMENT A human-centred approach to innovation However, digital transformation in healthcare transcends the technological realm. It must be rooted in the realities of patients and on-ground experiences that have emerged from years of clinical practice. Dr. Asma Al Mannaei, Executive Director of the of the Health Life Sciences Sector at the Department of Health – Abu Dhabi, underscores its impact; 'The future of health is patient-centred. Technology is a powerful enabler, but the true impact comes when innovations align with human need.'Technologies shown at ADGHW are shifting health towards proactive and predictive models of care, helping individuals manage chronic conditions, while algorithms interpret patient data to identify health risks before they escalate. ADVERTISEMENT Building a future-ready healthcare workforceThe success of this transformation depends equally on human capital. As AI and digital tools become more embedded in health workflows, there is a growing need for skilled professionals who can operate in hybrid, tech-enabled environments. 'Investing in workforce development is key to realising the benefits of digital health,' notes Dr. Rashed Obaid Al Suwaidi, Director General of the Abu Dhabi Public Health Centre (ADPHC) . 'Our role is to ensure that future clinicians and allied health professionals are equipped with both clinical and digital competencies, ensuring a seamless integration of innovation into care delivery.'This is true in the context of India as well, as it seeks to upskill its healthcare workforce to adopt emerging technologies. Abu Dhabi's initiatives present a model for India's academic and public-private institutions. The focus is on supporting the development of an AI-trained workforce capable of advancing both diagnostic precision and operational efficiency. Public health, equity, and global collaboration ADGHW 2025 also steered conversations on policy innovation, to drive an actionable agenda across global collaborators. A major milestone was the launch of a Global Declaration on Longevity and Precision Health, outlining an actionable agenda to extend both lifespan and healthspan through international cooperation and innovation, placing longevity at the heart of global health priorities. The Department of Health – Abu Dhabi (DoH) also signed a landmark Memorandum of Understanding (MoU), which focuses on advancing precision medicine and genomics in oncology, rare genetic disorders, and metabolic diseases, leveraging AI and collaborative research to pioneer new treatment pathways. This multi-stakeholder partnership included PureHealth, M42, Illumina, Khalifa University (KU), New York University Abu Dhabi (NYUAD), and the Institute for Healthier Living Abu Dhabi (IHLAD). In a world-first, Abu Dhabi unveiled the AI-powered Population Health Intelligence Framework—a learning health system designed to continuously predict, prevent, and respond to public health challenges through AI and real-time analytics.'Public health must be inclusive, data-informed, and anticipatory,' says H.E. Dr. Rached Obaid Al Suwaidi, Director-General of Abu Dhabi Public Health Center (ADPHC). 'Through ADGHW, we are advocating for integrated approaches that connect population health strategies with emerging digital tools.'This intersection of innovation and inclusion is critical as healthcare systems globally face challenges of scale, access, and sustainability. Through these measures, Abu Dhabi is positioning itself as both a contributor and convener in shaping the global health agenda. Infrastructure for impact Technology alone does not deliver transformation, it must be embedded within systems designed for agility, interoperability, and scale. Ibrahim Al Jallaf, Division Director of Digital Health at DoH, underscores that 'Our focus is on integrating digital health tools into a unified ecosystem. Whether it's through regulatory frameworks, investment incentives, or data platforms, we are building the infrastructure to support sustained impact.'ADGHW also provides the economic foundation for this transformation. By 2045, Abu Dhabi's life sciences sector is projected to contribute over AED 94 billion to GDP and generate more than 30,000 jobs. This economic vision is tightly interlinked with the health innovation agenda, making the Emirate a compelling hub for Indian health tech startups seeking Middle East expansion. From Abu Dhabi to the world As a year-round platform, ADGHW fosters a strategic bridge between global health priorities and local capacity, creating a space where data, expertise, and ambition leaders across government, academia, industry, and civil society, it presents an opportunity to co-create solutions that resonate far beyond borders, enhancing health outcomes not only for individuals but for entire communities and nations. Disclaimer: This content was authored by the content team of the ET Spotlight team. The news and editorial staff of ET had no role in the creation of this article. (You can now subscribe to our Economic Times WhatsApp channel) (This article is generated and published by ET Spotlight team. You can get in touch with them on etspotlight@
Time of India
24-06-2025
- Health
- Time of India
Rewriting the health playbook: How Abu Dhabi is scaling AI and digital care
In April 2025, global health leaders, policymakers, innovators, and researchers convened for Abu Dhabi Global Health Week (ADGHW)—a flagship initiative of the Department of Health – Abu Dhabi (DoH). Held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, the year-round global platform advances transformative solutions across health and life sciences. Health doesn't operate in a silo; it calls for critical thinking and collaboration among practitioners, policymakers, pharmaceutical leaders, researchers, and frontline healthcare workers accelerating shared health ambitions worldwide. The 2025 theme, 'Towards Longevity: Redefining Health and Well-being,' mirrors ADGHW's ambition: shifting from episodic treatment to continuous, preventive, and personalised care. The promise of digital health and AI One pressing theme that has dominated the public health discourse in the past few years is digital health and artificial intelligence (AI). Advanced technologies are unlocking new frontiers by improving access, enhancing clinical outcomes, and supporting more resilient health systems. From remote monitoring, AI-diagnostics, to telemedicine and predictive analysis, Abu Dhabi is reimagining care pathways to deliver personalised treatment while empowering providers with real-time, data-driven insights. ET Spotlight H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi According to H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, 'Digital health allows us to tailor care to the needs of each individual while improving access across diverse communities. Whether through telemedicine platforms or data-enabled prevention strategies, our focus is on strengthening system resilience and enhancing patient outcomes.' Abu Dhabi's growing trust-based health data and technical infrastructure presents a fertile ground for innovation. Initiatives such as Malaffi, the region's first Health Information Exchange, and the Emirati Genome Program are central to this vision. While the former facilitates real-time data sharing among care providers, the latter creates a unique dataset to analyse genetic predispositions to build better individual and population-level responses in health management. Live Events India's interest in scaling population health genomics (through initiatives such as the Genome India project, which aims to map the genetic diversity of the Indian population) aligns with such frameworks in Abu Dhabi. Data governance, ethical AI usage, and consent frameworks are some of the fronts where cross-border collaboration could be envisioned. Innovation Through Strategic Initiatives Initiatives announced at ADGHW 2025 reflect Abu Dhabi's role as a global health innovation leader, unveiling a suite of bold new initiatives that move digital health from concept to execution. Notably, the launch of the Health, Endurance, Longevity, and Medicine (HELM) Cluster—a partnership between the Abu Dhabi Investment Office, Mohamed bin Zayed University of Artificial Intelligence, and Hub71—signals a bold step toward advancing health life sciences, R&D, and building a robust ecosystem for medical innovation, pharmaceutical manufacturing, and biotechnology. The Startup Zone and Smart Health Hackathon spotlighted emerging innovators tackling real-world health challenges through AI-powered and digital-first approaches. The inaugural ADGHW Innovation Awards were also introduced, recognising breakthroughs that are driving meaningful improvements in patient outcomes, healthcare accessibility, and system efficiency. A human-centred approach to innovation However, digital transformation in healthcare transcends the technological realm. It must be rooted in the realities of patients and on-ground experiences that have emerged from years of clinical practice. Dr. Asma Al Mannaei, Executive Director of the of the Health Life Sciences Sector at the Department of Health – Abu Dhabi, underscores its impact; 'The future of health is patient-centred. Technology is a powerful enabler, but the true impact comes when innovations align with human need.' Technologies shown at ADGHW are shifting health towards proactive and predictive models of care, helping individuals manage chronic conditions, while algorithms interpret patient data to identify health risks before they escalate. B uilding a future-ready healthcare workforce The success of this transformation depends equally on human capital. As AI and digital tools become more embedded in health workflows, there is a growing need for skilled professionals who can operate in hybrid, tech-enabled environments. 'Investing in workforce development is key to realising the benefits of digital health,' notes Dr. Rashed Obaid Al Suwaidi, Director General of the Abu Dhabi Public Health Centre (ADPHC) . 'Our role is to ensure that future clinicians and allied health professionals are equipped with both clinical and digital competencies, ensuring a seamless integration of innovation into care delivery.' This is true in the context of India as well, as it seeks to upskill its healthcare workforce to adopt emerging technologies. Abu Dhabi's initiatives present a model for India's academic and public-private institutions. The focus is on supporting the development of an AI-trained workforce capable of advancing both diagnostic precision and operational efficiency. Public health, equity, and global collaboration ADGHW 2025 also steered conversations on policy innovation, to drive an actionable agenda across global collaborators. A major milestone was the launch of a Global Declaration on Longevity and Precision Health, outlining an actionable agenda to extend both lifespan and healthspan through international cooperation and innovation, placing longevity at the heart of global health priorities. The Department of Health – Abu Dhabi (DoH) also signed a landmark Memorandum of Understanding (MoU), which focuses on advancing precision medicine and genomics in oncology, rare genetic disorders, and metabolic diseases, leveraging AI and collaborative research to pioneer new treatment pathways. This multi-stakeholder partnership included PureHealth, M42, Illumina, Khalifa University (KU), New York University Abu Dhabi (NYUAD), and the Institute for Healthier Living Abu Dhabi (IHLAD). In a world-first, Abu Dhabi unveiled the AI-powered Population Health Intelligence Framework—a learning health system designed to continuously predict, prevent, and respond to public health challenges through AI and real-time analytics. 'Public health must be inclusive, data-informed, and anticipatory,' says H.E. Dr. Rached Obaid Al Suwaidi, Director-General of Abu Dhabi Public Health Center (ADPHC). 'Through ADGHW, we are advocating for integrated approaches that connect population health strategies with emerging digital tools.' This intersection of innovation and inclusion is critical as healthcare systems globally face challenges of scale, access, and sustainability. Through these measures, Abu Dhabi is positioning itself as both a contributor and convener in shaping the global health agenda. Infrastructure for impact Technology alone does not deliver transformation, it must be embedded within systems designed for agility, interoperability, and scale. Ibrahim Al Jallaf, Division Director of Digital Health at DoH, underscores that 'Our focus is on integrating digital health tools into a unified ecosystem. Whether it's through regulatory frameworks, investment incentives, or data platforms, we are building the infrastructure to support sustained impact.' ADGHW also provides the economic foundation for this transformation. By 2045, Abu Dhabi's life sciences sector is projected to contribute over AED 94 billion to GDP and generate more than 30,000 jobs. This economic vision is tightly interlinked with the health innovation agenda, making the Emirate a compelling hub for Indian health tech startups seeking Middle East expansion. From Abu Dhabi to the world As a year-round platform, ADGHW fosters a strategic bridge between global health priorities and local capacity, creating a space where data, expertise, and ambition converge. For leaders across government, academia, industry, and civil society, it presents an opportunity to co-create solutions that resonate far beyond borders, enhancing health outcomes not only for individuals but for entire communities and nations.
Arab News
31-03-2025
- Business
- Arab News
Cleveland Clinic and G42 to advance healthcare through artificial intelligence
Cleveland Clinic and G42, a global leader in artificial intelligence, are collaborating to drive AI-powered advancements in healthcare. As part of this initiative, the organizations will form a joint task force to evaluate, prioritize and accelerate potential projects and collaborative opportunities aimed at advancing AI adoption in healthcare. G42 is a technology group headquartered in Abu Dhabi, United Arab Emirates, known for its advanced innovation in artificial intelligence, digital infrastructure, and big data analytics solutions across a wide range of industries. Its healthcare portfolio company spanning 480 clinics in 26 countries, M42, leads some of the most groundbreaking health advancements in the industry, such as the Emirati Genome Program, the world's largest genomics initiative, and Malaffi, Abu Dhabi's Health Information Exchange. Cleveland Clinic is a global health system that includes 23 hospitals, 280 outpatient facilities, and American locations in northeast Ohio, Florida and Nevada and international locations in Toronto, Abu Dhabi, and London. In 2024, Cleveland Clinic provided 15.7 million outpatient encounters, 333,000 hospital admissions and observations, and 320,000 surgeries and procedures worldwide. 'Cleveland Clinic is committed to finding opportunities that improve patient safety, patient experience, patient outcomes and access,' said Cleveland Clinic CEO and president Tom Mihaljevic, MD, holder of the Morton L. Mandel CEO Chair. 'Artificial intelligence offers a tremendous opportunity to continue to advance and fulfill our mission of caring for life, researching for health and educating those who serve.' As part of the collaboration, G42 and Cleveland Clinic will explore and implement transformative AI-driven healthcare initiatives that have the potential to redefine patient care, enhance medical innovation, and drive operational efficiencies. These efforts will benefit not only the UAE and the wider region but extend globally, shaping the future of healthcare through intelligent, data-driven solutions. 'AI's potential to transform the healthcare industry remains largely untapped,' said Peng Xiao, Group CEO of G42. 'From deciphering the source code of life — our genome — to optimizing efficiencies across the entire patient journey, AI is paving the way for a future where care is not only more precise but also deeply personalized and preventative. We look forward to embarking on this journey alongside Cleveland Clinic and other global partners, harnessing AI to unlock new frontiers in medicine, empower clinicians with unprecedented insights, and ultimately, reshape the way humanity experiences health and longevity.' For the seventh consecutive year, Cleveland Clinic is the No. 2 hospital in the world, according to Newsweek's World's Best Hospitals 2025 list. The global healthcare system has pioneered many medical breakthroughs, including coronary artery bypass surgery, deep brain stimulation surgery to restore function after a stroke, and the first face transplant in the United States. In 2023, the IBM Quantum System One was installed at Cleveland Clinic; it is the first quantum computer in the world to be dedicated to healthcare research with an aim to help Cleveland Clinic accelerate biomedical discoveries.
Arabian Business
31-03-2025
- Business
- Arabian Business
Cleveland Clinic, G42 partner to advance AI in healthcare, driving innovation and patient care
Cleveland Clinic and G42, a global leader in artificial intelligence (AI), said they will collaborate to drive AI-powered advancements in healthcare. As part of this initiative, the two will form a joint task force to evaluate, prioritize and accelerate potential projects and collaborative opportunities aimed at advancing AI adoption in healthcare. Cleveland Clinic's AI-driven future The collaboration envisages G42 and Cleveland Clinic exploring and implementing transformative AI-driven healthcare initiatives that have the potential to redefine patient care, enhance medical innovation, and drive operational efficiencies. The efforts are expected to benefit not only the UAE and the wider region, but extend globally, shaping the future of healthcare through intelligent, data-driven solutions. 'AI's potential to transform the healthcare industry remains largely untapped,' said Peng Xiao, Group CEO of G42. 'From deciphering the source code of life – our genome – to optimising efficiencies across the entire patient journey, AI is paving the way for a future where care is not only more precise but also deeply personalised and preventative,' he said. Xiao said the company looks forward to embarking on this journey alongside Cleveland Clinic and other global partners, harnessing AI to unlock new frontiers in medicine, empower clinicians with unprecedented insights, and ultimately, reshape the way humanity experiences health and longevity. Tom Mihaljevic, CEO and President of Cleveland Clinic, said the healthcare company is committed to finding opportunities that improve patient safety, patient experience, patient outcomes and access. 'Artificial intelligence offers a tremendous opportunity to continue to advance and fulfill our mission of caring for life, researching for health and educating those who serve,' said Mihaljevic, who is also the Morton L. Mandel CEO Chair. G42, a technology group headquartered in Abu Dhabi, is known for its advanced innovation in AI, digital infrastructure, and big data analytics solutions across a wide range of industries. Its healthcare portfolio company spanning 480 clinics in 26 countries, M42, leads some of the most groundbreaking health advancements in the industry, such as the Emirati Genome Program, the world's largest genomics initiative, and Malaffi, Abu Dhabi's Health Information Exchange. Cleveland Clinic, which has a unit in Abu Dhabi, is a global health system that includes 23 hospitals and 280 outpatient facilities.
Zawya
26-03-2025
- Business
- Zawya
Cleveland Clinic and G42 to advance healthcare through artificial intelligence
ABU DHABI, United Arab Emirates: Cleveland Clinic and G42, a global leader in artificial intelligence (AI), are collaborating to drive AI-powered advancements in healthcare. As part of this initiative, the organizations will form a joint task force to evaluate, prioritize and accelerate potential projects and collaborative opportunities aimed at advancing AI adoption in healthcare. G42 is a technology group headquartered in Abu Dhabi, United Arab Emirates (UAE), known for its advanced innovation in artificial intelligence, digital infrastructure, and big data analytics solutions across a wide range of industries. Its healthcare portfolio company spanning 480 clinics in 26 countries, M42, leads some of the most groundbreaking health advancements in the industry, such as the Emirati Genome Program, the world's largest genomics initiative, and Malaffi, Abu Dhabi's Health Information Exchange. Cleveland Clinic is a global health system that includes 23 hospitals, 280 outpatient facilities, and American locations in northeast Ohio, Florida and Nevada and international locations in Toronto, Abu Dhabi, and London. In 2024, Cleveland Clinic provided 15.7 million outpatient encounters, 333,000 hospital admissions and observations, and 320,000 surgeries and procedures worldwide. 'Cleveland Clinic is committed to finding opportunities that improve patient safety, patient experience, patient outcomes and access,' said Cleveland Clinic CEO and President Tom Mihaljevic, M.D., holder of the Morton L. Mandel CEO Chair. 'Artificial intelligence offers a tremendous opportunity to continue to advance and fulfill our mission of caring for life, researching for health and educating those who serve.' As part of the collaboration, G42 and Cleveland Clinic will explore and implement transformative AI-driven healthcare initiatives that have the potential to redefine patient care, enhance medical innovation, and drive operational efficiencies. These efforts will benefit not only the UAE and the wider region but extend globally, shaping the future of healthcare through intelligent, data-driven solutions. 'AI's potential to transform the healthcare industry remains largely untapped,' said Peng Xiao, Group CEO of G42. 'From deciphering the source code of life - our genome - to optimizing efficiencies across the entire patient journey, AI is paving the way for a future where care is not only more precise but also deeply personalized and preventative. We look forward to embarking on this journey alongside Cleveland Clinic and other global partners, harnessing AI to unlock new frontiers in medicine, empower clinicians with unprecedented insights, and ultimately, reshape the way humanity experiences health and longevity." For the seventh consecutive year, Cleveland Clinic is the No. 2 hospital in the world, according to Newsweek's World's Best Hospitals 2025 list. The global healthcare system has pioneered many medical breakthroughs, including coronary artery bypass surgery, deep brain stimulation surgery to restore function after a stroke, and the first face transplant in the United States. In 2023, the IBM Quantum System One was installed at Cleveland Clinic; it is the first quantum computer in the world to be dedicated to healthcare research with an aim to help Cleveland Clinic accelerate biomedical discoveries. About Cleveland Clinic Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. Cleveland Clinic is consistently recognized in the U.S. and throughout the world for its expertise and care. Among Cleveland Clinic's 82,600 employees worldwide are more than 5,786 salaried physicians and researchers, and 20,700 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,728-bed health system that includes a 173-acre main campus near downtown Cleveland, 23 hospitals, 280 outpatient facilities, including locations in northeast Ohio; Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2024, there were 15.7 million outpatient encounters, 333,000 hospital admissions and observations, and 320,000 surgeries and procedures throughout Cleveland Clinic's health system. Patients came for treatment from every state and 112 countries. Visit us at Follow us at News and resources are available at About G42 G42 is a technology holding group, a global leader in creating visionary artificial intelligence for a better tomorrow. Born in Abu Dhabi and operating worldwide, G42 champions AI as a powerful force for good across industries. From molecular biology to space exploration and everything in between, G42 realizes exponential possibilities, today.
